祥生控股(02599.HK):流動性出現階段性問題 寬限期屆滿仍未支付1,200萬美元利息
祥生控股集團(02599.HK)公佈,有關發行2億美元2023年到期12釐優先票據,優先票據項下1,200萬美元利息已於今年2月18日到期應付,公司有30天寬限期支付利息。因受宏觀經濟、房地產市場環境及金融環境、多輪疫情等多種不利因素影響,集團流動性出現階段性問題。目前寬限期已屆滿,而公司並未於屆滿前支付利息。
公司指出,正對其流動性、業務整體經營和經營環境進行評估,積極實施有效的流動性解決措施,持續密切關注事項發展。同時,公司也將積極與債券持有人進行對話,以尋求並實施多種方式解決當前流動性問題,努力達成一致的解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.